See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: July 1, 2004

Keratoses Epilepsy Uterine Fibroids

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Keratoses

A research study evaluating the safety and efficacy of an investigational medicated cream for actinic keratosis on the face or balding scalp. Actinic keratosis is one of the most common precancerous skin conditions. Patches of rough skin or marks on the face or balding scalp may be signs of actinic keratosis. Research site located in Chaska, Minn.

More Information

Please see http://www.centerwatch.com/patient/studies/cat284.html.

-----

Epilepsy

A research study to evaluate the effects of two FDA-approved drugs in patients with partial seizures. Volunteers 16 or older who have a confident diagnosis of epilepsy and who have experienced at least two simple partial or complex partial seizures in the previous six months may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat62.html.

-----

Uterine Fibroids

A research study of an investigational medication for the treatment of uterine fibroids. Women 18 or older who have regular, heavy menstrual cycles (21 to 35 days) may be eligible. Research site located in Laurel, Md.

More Information

Please see http://www.centerwatch.com/patient/studies/cat322.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.